Bicara Therapeutics, Inc. (BCAX)
20.06
+0.77
(+3.99%)
USD |
NASDAQ |
May 19, 16:00
20.06
0.00 (0.00%)
After-Hours: 17:41
Bicara Therapeutics Market Cap : 1.318B for May 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bridgebio Oncology Therapeutics, Inc. | 699.33M |
| Viridian Therapeutics, Inc. | 1.764B |
| ACADIA Pharmaceuticals, Inc. | 3.510B |
| Agenus, Inc. | 128.88M |
| Alnylam Pharmaceuticals, Inc. | 39.34B |
Market Cap Related Metrics
| PEG Ratio | -0.1141 |
| Price to Book Value | 2.564 |
| Price | 20.06 |
| Earnings Yield | -13.82% |
| PEGY Ratio | -0.1141 |